OTCMKTS:RDGL Vivos (RDGL) Stock Price, News & Analysis $0.17 +0.01 (+6.25%) (As of 07/2/2024 ET) Add Compare Share Share Today's Range$0.16▼$0.1850-Day Range$0.12▼$0.2552-Week Range$0.04▼$0.26Volume1.22 million shsAverage Volume1.25 million shsMarket Capitalization$70.99 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest Get Vivos alerts: Email Address Ad Stansberry Research25th AmendmentIt's not surprising that talk of invoking the 25th Amendment (to remove Biden from office) has surfaced.But what happens next? About Vivos Stock (OTCMKTS:RDGL)Vivos Inc., a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals. The company was formerly known as Advanced Medical Isotope Corporation and changed its name to Vivos Inc. in December 2017. Vivos Inc. was incorporated in 1994 and is headquartered in Richland, Washington.Read More RDGL Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart RDGL Stock News HeadlinesJune 28, 2024 | globenewswire.comVivos Inc. Submits the Application to the FDA for Authority to Initiate Human Clinical TrialsMay 15, 2024 | finance.yahoo.comVivos Inc. (RDGL) Latest Stock News & Headlines - Yahoo FinanceJuly 3, 2024 | Stansberry Research (Ad)25th AmendmentIt's not surprising that talk of invoking the 25th Amendment (to remove Biden from office) has surfaced.May 3, 2024 | msn.comBarchart’s Hot Penny Stocks Screener Identifies Opportunity in Vivos (RDGL)April 27, 2024 | finance.yahoo.comVivos Inc. (RDGL)April 15, 2024 | morningstar.comVivos Inc RDGLApril 11, 2024 | finanznachrichten.deVivos Therapeutics, Inc: Vivos Therapeutics' Flagship CARE Oral Medical Devices Receive Full Approval for Medicare ReimbursementMarch 23, 2024 | benzinga.comVivos Stock (OTC:RDGL), Quotes and News SummaryJuly 3, 2024 | Stansberry Research (Ad)25th AmendmentIt's not surprising that talk of invoking the 25th Amendment (to remove Biden from office) has surfaced.February 23, 2024 | thestreet.comVivos IncFebruary 22, 2024 | investorplace.com3 Stocks to Turn $1,000 Into $1 Million: February 2024January 31, 2024 | theglobeandmail.comSpeculation Tuesday: 2 Call Options and 1 Penny Stock to ConsiderDecember 21, 2023 | msn.comNew Hope In Cancer Battle: FDA Grants Breakthrough Device Status To Vivos Inc.'s RadioGelDecember 20, 2023 | finance.yahoo.comRadiogel Precision Radionuclide Therapy Receives FDA Breakthrough Device DesignationDecember 20, 2023 | finance.yahoo.comRadiogel™ Precision Radionuclide Therapy™ Receives FDA Breakthrough Device DesignationAugust 7, 2023 | finance.yahoo.comVivos Inc. Announces Certification of Three New IsoPet® Precision Radionuclide Therapy Regional ClinicsMay 15, 2023 | finance.yahoo.comVivos Inc. (RDGL) Stock Historical Prices & Data - Yahoo FinanceJanuary 11, 2023 | finance.yahoo.comVivos Inc Files a New Patent on Alternate Particles for Precision Radionuclide TherapyJanuary 5, 2023 | reuters.comRDGL.PK - Vivos Inc | Stock Price & Latest News | ReutersJanuary 3, 2023 | finance.yahoo.comVivos Inc Files a New Patent on Precision Radionuclide Therapy Support System EquipmentSeptember 15, 2022 | stockhouse.comVivos Inc Files a New Patent on the Hydrogel Component of IsoPet®/RadioGel(TM)September 14, 2022 | finance.yahoo.comVivos Inc Files a New Patent on the Hydrogel Component of IsoPet®/RadioGel™August 18, 2022 | nz.finance.yahoo.comDua Lipa's LBD Looked Like a Pair of Pants With StrapsAugust 16, 2022 | uk.investing.comGreat Elm Group And 3 Other Stocks Under $5 Insiders Are Aggressively BuyingAugust 16, 2022 | finance.yahoo.comVivos Inc. Announces a New IsoPet® Precision Radionuclide Therapy Regional Clinic for Equine TherapyJuly 15, 2022 | benzinga.comVivos (OTC:RDGL), Analyst Ratings, Price Targets, PredictionsJuly 14, 2022 | benzinga.comVivos (OTC:RDGL), Earnings Estimates, EPS, and RevenueSee More Headlines Receive RDGL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Vivos and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today7/02/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorFinance Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolOTCMKTS:RDGL CUSIPN/A CIK1449349 Webwww.radiogel.com Phone(509) 736-4000Fax509-736-4007Employees1Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.01) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-2,890,000.00 Net MarginsN/A Pretax Margin-16,873.68% Return on EquityN/A Return on Assets-201.99% Debt Debt-to-Equity RatioN/A Current Ratio18.48 Quick Ratio18.48 Sales & Book Value Annual Sales$20,000.00 Price / Sales3,549.69 Cash FlowN/A Price / Cash FlowN/A Book Value($0.02) per share Price / Book-8.50Miscellaneous Outstanding Shares417,610,000Free Float340,353,000Market Cap$70.99 million OptionableNot Optionable Beta1.01 Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report Key ExecutivesDr. Michael K. Korenko Ph.D. (Age 78)CEO, President & Director Comp: $266.39kDr. Carlton M. Cadwell D.D.S. (Age 79)Independent Chairman & Secretary Mr. Michael H. Pollack CPA (Age 58)Chief Financial Officer Dr. David J. Swanberg M.S. (Age 67)P.E., Chief Technical Manager Dr. Nigel R. Stevenson B.Sc.Ph.D., Chief Science OfficerDr. Fu-Min SuChief Radio Chemist & Radiation Safety OfficerMore ExecutivesKey CompetitorsTactile Systems TechnologyNASDAQ:TCMDOrchestra BioMedNASDAQ:OBIOCVRxNASDAQ:CVRXPulmonxNASDAQ:LUNGBeauty HealthNASDAQ:SKINView All Competitors RDGL Stock Analysis - Frequently Asked Questions How have RDGL shares performed in 2024? Vivos' stock was trading at $0.0723 on January 1st, 2024. Since then, RDGL stock has increased by 135.1% and is now trading at $0.17. View the best growth stocks for 2024 here. Are investors shorting Vivos? Vivos saw a drop in short interest in June. As of June 15th, there was short interest totaling 46,000 shares, a drop of 84.2% from the May 31st total of 290,800 shares. Based on an average daily trading volume, of 1,981,900 shares, the days-to-cover ratio is presently 0.0 days. View Vivos' Short Interest. How do I buy shares of Vivos? Shares of RDGL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:RDGL) was last updated on 7/3/2024 by MarketBeat.com Staff From Our PartnersOperation Replace Biden is a GoLast night’s debate proved me right: Joe Biden will be replaced. I’ve been making this warning for months… ...The Freeport Society | SponsoredBuy this small stock before coming AI Tidal WaveThe internet generated more wealth than any other innovation in history - creating hundreds of thousands of ne...Chaikin Analytics | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | SponsoredRe: We’re giving you all this for less than a pair of socksThe Only Trading Tool You'll Need This Year Forget juggling multiple subscriptions and confusing indicator...StockEarnings | Sponsored1k a day while computer does all work?What I discovered is now helping me take in more than 1k a day. It's like a "magic key" to passive income ...Digital Mavericks Media | SponsoredThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredThe End of Privacy for Americans… Get Out of Cash Now!Unlock the Secret to Outsmarting Inflation with "The Trump Loophole" That investment? Gold.Golden Crest | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vivos Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vivos With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
